Brainstorm Cell Valuation
| BCLI Stock | USD 0.58 0.01 1.75% |
Brainstorm Cell is overvalued. Brainstorm Cell Ther shows a prevailing Real Value of $0.5 per share. The current price of the firm is $0.58. Our model approximates the value of Brainstorm Cell Ther from analyzing the firm fundamentals such as return on equity of -11.22, and Current Valuation of 6.79 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Brainstorm Cell's valuation include:
Overvalued
Today
Please note that Brainstorm Cell's price fluctuation is out of control at this time. Calculation of the real value of Brainstorm Cell Ther is based on 3 months time horizon. Increasing Brainstorm Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Brainstorm Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brainstorm Stock. However, Brainstorm Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.58 | Real 0.5 | Target 17.0 | Hype 0.58 |
The intrinsic value of Brainstorm Cell's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Brainstorm Cell's stock price.
Estimating the potential upside or downside of Brainstorm Cell Therapeutics helps investors to forecast how Brainstorm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brainstorm Cell more accurately as focusing exclusively on Brainstorm Cell's fundamentals will not take into account other important factors: When choosing an evaluation method for Brainstorm Cell Ther, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Brainstorm Cell Cash |
|
Brainstorm Cell Total Value Analysis
Brainstorm Cell Therapeutics is currently expected to have valuation of 6.79 M with market capitalization of 5.96 M, debt of 720 K, and cash on hands of 12.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Brainstorm Cell fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.79 M | 5.96 M | 720 K | 12.24 M |
Brainstorm Cell Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Brainstorm Cell has an asset utilization ratio of 46.34 percent. This signifies that the Company is making $0.46 for each dollar of assets. An increasing asset utilization means that Brainstorm Cell Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Brainstorm Cell Profitability Analysis
Taking into consideration Brainstorm Cell's profitability measurements, Brainstorm Cell Therapeutics is yielding more profit at this time then in previous quarter. It has a moderate odds of reporting better profitability numbers in March. Profitability indicators assess Brainstorm Cell's ability to earn profits and add value for shareholders.Net Income | First Reported 2002-06-30 | Previous Quarter -2.9 M | Current Value -2.1 M | Quarterly Volatility 2.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.21 | 0.16 |
|
|
For Brainstorm Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Brainstorm Cell Ther to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Brainstorm Cell utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Brainstorm Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Brainstorm Cell over time as well as its relative position and ranking within its peers.
Brainstorm Cell Earnings per Share Projection vs Actual
By analyzing Brainstorm Cell's earnings estimates, investors can diagnose different trends across Brainstorm Cell's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Brainstorm Cell Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.Brainstorm Cell Ownership Allocation
Brainstorm Cell Therapeutics shows 9.36 percent of its outstanding shares held by insiders and 0.02 percent owned by other corporate entities.Brainstorm Cell Profitability Analysis
The company reported the previous year's revenue of 849 K. Net Loss for the year was (11.62 M) with profit before overhead, payroll, taxes, and interest of 0.About Brainstorm Cell Valuation
An absolute valuation paradigm, as applied to Brainstorm Stock, attempts to find the value of Brainstorm Cell Ther based on its fundamental and basic technical indicators. By analyzing Brainstorm Cell's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Brainstorm Cell's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brainstorm Cell. We calculate exposure to Brainstorm Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brainstorm Cell's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 764.1 K | 802.3 K | |
| Pretax Profit Margin | 12.32 | 14.98 | |
| Operating Profit Margin | (12.40) | (11.78) | |
| Net Profit Margin | 12.32 | 15.11 | |
| Gross Profit Margin | 0.16 | 0.21 |
Brainstorm Cell Current Valuation Indicators
Valuation refers to the process of determining the present value of Brainstorm Cell Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Brainstorm we look at many different elements of the entity such as Brainstorm's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Brainstorm Cell, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Brainstorm Cell's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Brainstorm Cell's worth.Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |